Citations

1. Petri MA (2005). Systemic lupus erythematosus: Clinical aspects. In WJ Koopman, LW Moreland, eds., Arthritis and Allied Conditions: A Textbook of Rheumatology, 15th ed., vol. 2, pp.1473–1496. Philadelphia: Lippincott Williams and Wilkins.

2. Cooper GS, et al. (2002). Hormonal and reproductive risk factors for development of systemic lupus erythematosus. Arthritis and Rheumatism, 46(7): 1830–1839.

3. Petri MA, et al. (2005). Combined oral contraceptives in women with systemic lupus erythematosus. New England Journal of Medicine, 353(24): 2550–2558.

4. Schur PH (2004). Systemic lupus erythematosus. In L Goldman, D Ausiello, eds., Cecil Textbook of Medicine, 22nd ed., vol. 2, pp. 1660–1670. Philadelphia: Saunders.

5. Keyser RE, et al. (2003). Evidence for aerobic insufficiency in women with systemic lupus erythematosus. Arthritis and Rheumatism, 49(1): 16–22.

6. Lockshin MD (2005). Systemic lupus erythematosus. In DC Dale, DD Federman, eds., ACP Medicine, section 15, chap. 4. New York: WebMD.

7. Hellmann DB, Stone JH (2005). Systemic lupus erythematosus section of Arthritis and musculoskeletal disorders. In LM Tierney et al., eds., Current Medical Diagnosis and Treatment, 44th ed., pp. 807–811. New York: McGraw-Hill.

8. Bruce IN, et al. (2003). Risk factors for coronary heart disease in women with systemic lupus erythematosus. Arthritis and Rheumatism, 48(11): 3159–3167.

9. Trager J, Ward M (2001). Mortality and causes of death in systemic lupus erythematosus. Current Opinion in Rheumatology, 13(5): 345–351.

10. Wofsy D (2005). Therapy of systemic lupus erythematosus. In WJ Koopman, LW Moreland, eds., Arthritis and Allied Conditions: A Textbook of Rheumatology, 15th ed., vol. 2, pp. 1561–1574. Philadelphia: Lippincott Williams and Wilkins.

11. Jessop S (2005). Drugs for discoid lupus erythematosus. Cochrane Database of Systematic Reviews (2). Oxford: Update Software.

12. Costenbader KH, et al. (2004). Cigarette smoking and the risk of systemic lupus erythematosus. Arthritis and Rheumatism, 50(3): 849–857.

13. Hahn BH, et al. (2005). Pathogenesis of systemic lupus erythematosus. In ED Harris et al., eds., Kelley's Textbook of Rheumatology, 7th ed., vol. 2, pp. 1174–1200. Philadelphia: Elsevier Saunders.

14. Ghaussy NO, et al. (2003). Cigarette smoking and disease activity in systemic lupus erythematosus. Journal of Rheumatology, 30(6): 1215–1221.

15. Pope J, et al. (2003). Frequency of adverse drug reactions in patients with systemic lupus erythematosus. Journal of Rheumatology, 30(3): 480–484.

16. Hahn BH (2005). Management of systemic lupus erythematosus. In ED Harris et al., eds., Kelley's Textbook of Rheumatology, 7th ed., vol. 2, pp. 1225–1247. Philadelphia: Elsevier Saunders.

17. Wallace DJ (2002). Management of lupus erythematosus: Recent insights. Current Opinion in Rheumatology, 14(3): 212–219.

18. Petri MA, et al. (2004). Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus. Arthritis and Rheumatism, 50(9): 2858–2868.

19. Petri M (2001). Systemic lupus erythematosus (including pregnancy and antiphospholipid antibody syndrome). In MH Weisman et al., eds., Treatment of the Rheumatic Diseases: Companion to Kelley's Textbook of Rheumatology, 2nd ed., pp. 274–288. Philadelphia: W.B. Saunders.

Other Works Consulted

• McMurray RW, May W (2003). Sex hormones and systemic lupus erythematosus: Review and meta-analysis. Arthritis and Rheumatism, 48(8): 2100–2110.